In 1998, astronomers discovered dark energy. The finding, which transformed our conception of the cosmos, came with a little-known consequence: It threw a wrench into the already daunting task of ...

States will share $10 billion for rural health care next year in a program that aims to offset the Trump administration's massive budget cuts to rural hospitals, federal officials announced Monday.

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Recursion Pharmaceuticals, Inc. (RXRX) recently received a notable upgrade from JP Morgan analyst Eric Joseph, who shifted his rating to “Overweight” on December 17, 2025. This upgrade comes as the ...

The items were taken in the late 19th century from what was then called the Dutch East Indies. Indonesia had been trying to get them back for decades. By Nina Siegal Reporting from Amsterdam The ...

Billy Strings rolled into Austin, Texas over the weekend for the final performances in a long year on the road. Even seasoned road warriors like Strings and his band of Billy Failing, Alex Hargreaves, ...

Years ago, an audacious Fields medalist outlined a sweeping program that, he claimed, could be used to resolve a major problem in algebraic geometry. Other mathematicians had their doubts. Now he says ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Gwyneth Paltrow, in case you didn’t know, hosts a podcast tied to her wellness brand Goop. She gets some good guests and on the latest episode, she speaks with Charli XCX. During the show, Charli gave ...

Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...

Recursion Pharmaceuticals stock jumped 16% on October 8, 2025, reaching around $6.08 after falling 5.4% the previous day on broader market weakness. The company reported Q2 2025 revenue of $19.2 ...